Emergency pharmacists resolving outpatient prescription issues
Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues: a Descriptive Study
NA · Methodist Health System · NCT06222424
This study is testing whether allowing emergency pharmacists to write prescriptions for patients after they leave the emergency room can help fix prescription problems and improve care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 350 (estimated) |
| Sex | All |
| Sponsor | Methodist Health System (other) |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT06222424 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a Collaborative Practice Agreement (CPA) that grants Emergency Medicine Pharmacists (EMPs) the authority to write prescriptions for resolving outpatient prescription issues. By documenting the prescriptions written by EMPs after patient discharge, the study aims to assess the impact on emergency department workflow and the rate of prescription errors. The goal is to reduce the number of new prescriptions that need to be sent by physicians and mid-level providers, ultimately improving patient care and reducing emergency department re-visits.
Who should consider this trial
Good fit: Ideal candidates include patients at Methodist Charlton Medical Center who had a prescription issued by an EMP during the specified study period.
Not a fit: Patients who left the emergency department against medical advice or had misclassified prescription issues will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could streamline outpatient prescription management and enhance patient safety by reducing prescription errors.
How similar studies have performed: While similar collaborative practice agreements have shown promise in other settings, this specific approach is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP. Exclusion Criteria: * CPA actions were misclassified as discharge prescription issue resolutions. * Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions. * Patients documented to have left the ED against medical advice.
Where this trial is running
Dallas, Texas
- Clinical Research Institute at Methodist Health System — Dallas, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Kevin Burnham, Pharm.D. — Methodist Health System
- Study coordinator: Jeff Wilson
- Email: mhsirb@mhd.com
- Phone: 214-947-1279
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Outpatient Prescription Issues